
About Startell Bioceuticals
Startell Bioceuticals is a Healthcare company. Manufacturing and distributing innovative pharmaceutical medicines in India and the USA. The company has 58 employees. Its Indian entity Startell Bioceuticals Private Limited reported revenue of βΉ7.08 Cr. Startell Bioceuticals offers products and services including Medicines and Health Solutions. Its focus areas include Biotechnology, Bioceuticals Development, Innovative Medicines and Pharmaceuticals.
Company details
Startell Bioceuticals is recognized as an emerging entity in the Indian pharmaceutical industry, where high-quality medicines are provided across various therapeutic categories to enhance human health. A commitment to ethics and integrity is maintained, with innovative and cost-effective solutions being offered to improve lives. Operations are based in India and the USA, emphasizing collaboration to achieve excellence in medicine delivery. Trust and efficiency are prioritized in all activities, ensuring accessibility for all.
- Employees 58
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website startellbio.com
- Legal Name Startell Bioceuticals Pvt. Ltd
- Date of Incorporation 25 Apr, 2016
- Jurisdiction Majiwada, Maharashtra, India
- Indian entity revenue₹7.08 Cr
FY 2025 · +30% YoY
- Indian entity net profit₹8.1 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹17.1 Lakh
FY 2025 · 2% margin
- Employee Count58
Associated legal entities of Startell Bioceuticals
Startell Bioceuticals operates through Startell Bioceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Startell Bioceuticals Private Limited CIN U52394MH2016PTC280155 | Active | 25 Apr 2016 | Majiwada, Maharashtra | ₹7.1 Cr | 58 | 2 | View details |
Products & Services of Startell Bioceuticals
Startell Bioceuticals offers a comprehensive portfolio of products and services, including Medicines and Health Solutions.
Innovative and cost-effective medicines are provided across various therapeutic categories to enhance human health
Solutions are offered to improve human life through high-quality and ethical pharmaceutical practices
Board of directors of Startell Bioceuticals Private Limited (Startell Bioceuticals)
Startell Bioceuticals Private Limited is the primary company behind Startell Bioceuticals. The board of Startell Bioceuticals Private Limited currently have 2 directors; the longest-serving is Bijal Kalpesh Desai, appointed in 2016. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bijal Kalpesh Desai DIN 07477776 | Director | 25 Apr 2016 | 10 yrs 6 mo | Startell Bioceuticals Private Limited |
| Nilesh Ramesh Sarode DIN 05115568 | Director | 05 May 2025 | 1 yr 6 mo | Startell Bioceuticals Private Limited |
Financials of Startell Bioceuticals
Figures of Startell Bioceuticals Private Limited, the primary company behind Startell Bioceuticals, for FY 2025. Revenue was ₹7.08 Cr (+30% year on year). Net profit was ₹8.1 Lakh (1% margin). EBITDA was ₹17.1 Lakh (2% margin). Revenue has grown at a compounded annual rate of +18% over three years and -1% over five years.
- ₹7.08 CrRevenue · FY 2025 · +30% YoY
- ₹8.1 LakhNet profit · 1% margin
- ₹17.1 LakhEBITDA · 2% margin
- ₹35 LakhPaid-up capital
- 58Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Startell Bioceuticals Private Limited are on its company page.
Detailed financial statements for Startell Bioceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Startell Bioceuticals
Startell Bioceuticals has 58 employees.
The primary company behind Startell Bioceuticals, Startell Bioceuticals Private Limited, reported revenue of βΉ7.08 Cr for FY 2025, up 30% year on year.
Startell Bioceuticals is recognized as an emerging entity in the Indian pharmaceutical industry, where high-quality medicines are provided across various therapeutic categories to enhance human health. A commitment to ethics and integrity is maintained, with innovative and cost-effective solutions being offered to improve lives. Operations are based in India and the USA, emphasizing collaboration to achieve excellence in medicine delivery. Trust and efficiency are prioritized in all activities, ensuring accessibility for all.
Startell Bioceuticals offers Medicines and Health Solutions.
Startell Bioceuticals operates through Startell Bioceuticals Private Limited.
The legal entities of Startell Bioceuticals currently have 2 directors, including Nilesh Ramesh Sarode, Bijal Kalpesh Desai.